litlas
ログインアカウント作成

Robert W. Shafer

1984–2025 年に発表

別表記
Robert W Shafer
142
論文数
22,647
被引用数
88
h 指数
136
i10 指数

被引用数

Robert W. Shafer の年別被引用数1984 年: 被引用 2 件1991 年: 被引用 4 件1992 年: 被引用 7 件1993 年: 被引用 16 件1994 年: 被引用 13 件1995 年: 被引用 33 件1996 年: 被引用 40 件1997 年: 被引用 32 件1998 年: 被引用 51 件1999 年: 被引用 65 件2000 年: 被引用 68 件2001 年: 被引用 56 件2002 年: 被引用 66 件2003 年: 被引用 81 件2004 年: 被引用 128 件2005 年: 被引用 120 件2006 年: 被引用 148 件2007 年: 被引用 119 件2008 年: 被引用 188 件2009 年: 被引用 180 件2010 年: 被引用 190 件2011 年: 被引用 212 件2012 年: 被引用 180 件2013 年: 被引用 173 件2014 年: 被引用 118 件2015 年: 被引用 136 件2016 年: 被引用 137 件2017 年: 被引用 76 件2018 年: 被引用 106 件2019 年: 被引用 414 件2020 年: 被引用 325 件2021 年: 被引用 353 件2022 年: 被引用 532 件2023 年: 被引用 299 件2024 年: 被引用 454 件2025 年: 被引用 235 件2026 年: 被引用 14 件1985〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,902 件、この内訳の 27.5%イギリス: 引用元論文 513 件、この内訳の 7.4%中国: 引用元論文 309 件、この内訳の 4.5%南アフリカ: 引用元論文 259 件、この内訳の 3.7%ドイツ: 引用元論文 256 件、この内訳の 3.7%フランス: 引用元論文 250 件、この内訳の 3.6%カナダ: 引用元論文 221 件、この内訳の 3.2%イタリア: 引用元論文 219 件、この内訳の 3.2%スペイン: 引用元論文 203 件、この内訳の 2.9%スイス: 引用元論文 202 件、この内訳の 2.9%オランダ: 引用元論文 169 件、この内訳の 2.4%ベルギー: 引用元論文 136 件、この内訳の 2%
0%27.5%その他 33%

機関

分野

  • Medicine65%
  • Immunology and Microbiology15.4%
  • Biochemistry, Genetics and Molecular Biology10.2%
  • Computer Science3.2%
  • Agricultural and Biological Sciences1.9%
  • Mathematics1%
  • その他3.3%

トピック

  • HIV Research and Treatment14.4%
  • HIV/AIDS drug development and treatment14.3%
  • HIV/AIDS Research and Interventions9%
  • SARS-CoV-2 and COVID-19 Research4.6%
  • HIV-related health complications and treatments3.4%
  • COVID-19 Clinical Research Studies2.4%
  • その他51.9%

共著者

全論文

検索で開く
  1. The biological and clinical significance of emerging SARS-CoV-2 variants

    著者: Kaiming Tao, Philip L. Tzou, Janin Nouhin, Ravindra K. Gupta, Túlio de Oliveira, Sergei L. Kosakovsky Pond, Daniela Fera, Robert W. Shafer - Nature Reviews Genetics 2021 被引用: 1,108

  2. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic

    著者: Hector Bonilla, Tom Quach, Anushri Tiwari, Andres Bonilla, Mitchell G. Miglis, Phillip Yang, L. Eggert, Husham Sharifi, Audra Horomanski, Aruna Subramanian, Liza Smirnoff, Norah Simpson, Houssan Halawi, Oliver Sum‐Ping, Agnieszka Kalinowski, Zara M. Patel, Robert W. Shafer, Linda N. Geng - Frontiers in Neurology 2023 被引用: 130

  3. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)

    著者: Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker, Lindsey R. Baden, Vincent Chi‐Chung Cheng, Kathryn M. Edwards, Jason C Gallagher, Rajesh T. Gandhi, William J. Muller, Mari Nakamura, John C. O’Horo, Robert W. Shafer, Shmuel Shoham, M. Hassan Murad, Reem A. Mustafa, Shahnaz Sultan, Yngve Falck–Ytter - Clinical Infectious Diseases 2022 被引用: 201

  4. Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection

    著者: Linda N. Geng, Hector Bonilla, Haley Hedlin, Karen B. Jacobson, Lü Tian, Prasanna Jagannathan, Phillip C. Yang, Aruna Subramanian, Jane W. Liang, Sa Shen, Yaowei Deng, Blake Shaw, Bren Botzheim, Manisha S. Desai, Divya Pathak, Yasmin Jazayeri, Daniel Thai, Andrew O’Donnell, Sukanya Mohaptra, Zenita Leang, Gabriella Z. M. Reynolds, Erin F. Brooks, Ami S. Bhatt, Robert W. Shafer, Mitchell G. Miglis, Tom Quach, Anushri Tiwari, Anindita Banerjee, Rene N. Lopez, Magdia De Jesus, Lawrence Charnas, Paul J. Utz, Upinder Singh - JAMA Internal Medicine 2024 被引用: 106

  5. 2015 update of the drug resistance mutations in HIV-1

    著者: Annemarie M. J. Wensing, Vincent Cálvez, Günthard, Huldrych F, Johnson, Victoria A, Huldrych F. Günthard, Roger Paredes, Robert W. Shafer, Douglas D. Richman - 2015 被引用: 361

  6. Web Resources for HIV Type 1 Genotypic-Resistance Test Interpretation

    著者: T. F. Liu, Robert W. Shafer - Clinical Infectious Diseases 2006 被引用: 672

  7. HIV-1 drug resistance and resistance testing

    著者: Dana Clutter, Michael R. Jordan, Silvia Bertagnolio, Robert W. Shafer - Infection Genetics and Evolution 2016 被引用: 335

  8. Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study

    著者: Jennifer Smith, Loveleen Bansi‐Matharu, Valentina Cambiano, Dobromir Dimitrov, Anna Bershteyn, David van de Vijver, Katharine Kripke, Paul Revill, Marie‐Claude Boily, Gesine Meyer‐Rath, Isaac Taramusi, Jens Lundgren, Joep J. van Oosterhout, Daniel R. Kuritzkes, Robin Schaefer, Mark J. Siedner, Jonathan Schapiro, Sinéad Delany‐Moretlwe, Raphael J. Landovitz, Charles Flexner, Michael R. Jordan, François Venter, Mopo Radebe, David H. Brown Ripin, Sarah M. Jenkins, Danielle Resar, Carolyn Amole, Maryam Shahmanesh, Ravindra K. Gupta, Elliot Raizes, Cheryl Johnson, Seth Inzaule, Robert W. Shafer, Mitchell Warren, Sarah E. Stansfield, Roger Paredes, Andrew Phillips - The Lancet HIV 2023 被引用: 64

  9. Rationale and Uses of a Public HIV Drug‐Resistance Database

    著者: Robert W. Shafer - The Journal of Infectious Diseases 2006 被引用: 428

  10. Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons

    著者: Philip L. Tzou, Kaiming Tao, Sergei L. Kosakovsky Pond, Robert W. Shafer - PLoS ONE 2022 被引用: 122

  11. SARS-CoV-2 Antiviral Therapy

    著者: Kaiming Tao, Philip L. Tzou, Janin Nouhin, Hector Bonilla, Prasanna Jagannathan, Robert W. Shafer - Clinical Microbiology Reviews 2021 被引用: 99

  12. Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database

    著者: Robert W. Shafer, Derek Stevenson, Bryan Chan - Nucleic Acids Research, Nucleic Acids Res. 1999 被引用: 932

  13. Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations

    著者: Santiago Ávila‐Ríos, Neil Parkin, Ronald Swanstrom, Roger Paredes, Robert W. Shafer, Hezhao Ji, Rami Kantor - Viruses 2020 被引用: 87

  14. 2017 Update of the Drug Resistance Mutations in HIV-1.

    著者: Annemarie M. J. Wensing, Vincent Cálvez, Huldrych F. Günthard, Victoria A. Johnson, Roger Paredes, Deenan Pillay, Robert W. Shafer, Douglas D. Richman - 2016 被引用: 165

  15. Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance

    著者: Philip L. Tzou, Soo‐Yon Rhee, Diane Descamps, Dana Clutter, Bradley Hare, Orna Mor, Maxime Grudé, Neil Parkin, Michael R. Jordan, Silvia Bertagnolio, Jonathan Schapiro, P. Richard Harrigan, Anna María Geretti, Anne‐Geneviève Marcelin, Robert W. Shafer, on behalf of the WHO HIVResNet Working Groups - Journal of Antimicrobial Chemotherapy 2019 被引用: 89

  16. A systematic review of the genetic mechanisms of dolutegravir resistance

    著者: Soo‐Yon Rhee, Philip Grant, Philip L. Tzou, Geoffrey Barrow, P. Richard Harrigan, John P. A. Ioannidis, Robert W. Shafer - Journal of Antimicrobial Chemotherapy 2019 被引用: 153

  17. Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review

    著者: Carolyn Chu, Kaiming Tao, Vinie Kouamou, Ava Avalos, Jake Scott, Philip Grant, Soo‐Yon Rhee, Suzanne M. McCluskey, Michael R. Jordan, Rebecca L. Morgan, Robert W. Shafer - Viruses 2024 被引用: 55

  18. Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review

    著者: Kaiming Tao, Soo‐Yon Rhee, Carolyn Chu, Ava Avalos, Amrit Ahluwalia, Ravindra K. Gupta, Michael R. Jordan, Robert W. Shafer - Viruses 2023 被引用: 51

  19. Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

    著者: Diane Bennett, Ricardo Camacho, Dan Oţelea, Daniel R. Kuritzkes, Hervé Fleury, Mark Kiuchi, Walid Heneine, Rami Kantor, Michael R. Jordan, Jonathan Schapiro, Anne–Mieke Vandamme, Paul Sandstrom, Charles A. Boucher, David van de Vijver, Soo‐Yon Rhee, Tommy F. Liu, Deenan Pillay, Robert W. Shafer - PLoS ONE 2009 被引用: 960

  20. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

    著者: John Gregson, Michele W. Tang, Nicaise Ndembi, Raph L Hamers, Soo‐Yon Rhee, Vincent C. Marconi, Lameck Diero, Katherine Brooks, Kristof Theys, Tobias Rinke de Wit, Mônica Barcellos Arruda, Fréderico Duarte Garcia, Susana Monge, Huldrych F. Günthard, Christopher J. Hoffmann, Phyllis J. Kanki, N. Kumarasamy, Bernard Kerschberger, Orna Mor, Charlotte Charpentier, Eva Todesco, Casper Rokx, Luuk Gras, Elias K Helvas, Henry Sunpath, Domenico Di Carlo, Antonio Antinori, Massimo Andreoni, Alessandra Latini, Cristina Mussini, Avelin F. Aghokeng, Anders Sönnerborg, Ujjwal Neogi, W. Jeffrey Fessel, Simon Agolory, Chunfu Yang, José Luís Blanco, James Juma, Erasmus Smit, Daniel Schmidt, Christine Watera, Juliet Asio, Wilford Kurungi, Anna Tostevin, Tal El‐Hay, Nathan Clumeck, Dominique Goedhals, Cloete van Vuuren, Philip Armand Bester, Caroline Sabin, Irene Mukui, Maria Mercedes Santoro, Carlo Federico Perno, Gillian Hunt, Lynn Morris, Ricardo Camacho, Túlio de Oliveira, Deenan Pillay, Eugene Schulter, Akio Murakami-Ogasawara, Gustavo Reyes‐Terán, Karla Romero, Santiago Ávila‐Ríos, Sunee Sirivichayakul, Kiat Ruxrungtham, Suwanna Mekprasan, David Dunn, Pontiano Kaleebu, Elliot Raizes, Rami Kantor, Robert W. Shafer, Ravindra K. Gupta - The Lancet Infectious Diseases 2016 被引用: 275

  21. HIV-1 Antiretroviral Resistance

    著者: Michele W. Tang, Robert W. Shafer - Drugs 2012 被引用: 324

  22. Emerging SARS-CoV-2 Resistance After Antiviral Treatment

    著者: Trevor J. Tamura, Manish C. Choudhary, Rinki Deo, Fizah Yousuf, A. Gomez, Gregory E. Edelstein, Julie Boucau, Owen T. Glover, Mamadou Barry, Rebecca F. Gilbert, Zahra Reynolds, Yijia Li, Dessie Tien, Tammy D. Vyas, Eliza Passell, Karry Su, Sarah Drapkin, Emory Abar, Yumeko Kawano, Jeffrey A. Sparks, Zachary S. Wallace, Jatin M. Vyas, Robert W. Shafer, Mark J. Siedner, Amy K. Barczak, Jacob E. Lemieux, Jonathan Z. Li, POSITIVES Study Team - JAMA Network Open 2024 被引用: 42

  23. Combating antimicrobial resistance in malaria, HIV and tuberculosis

    著者: Maëlle Duffey, Robert W. Shafer, Juliano Timm, Jeremy N. Burrows, Nader Fotouhi, Mark I. Cockett, Didier Leroy - Nature Reviews Drug Discovery 2024 被引用: 34

  24. Highly active antiretroviral therapy (Haart) for the treatment of infection with human immunodeficiency virus type 1

    著者: Robert W. Shafer, Dominique A. Vuitton - Biomedicine & Pharmacotherapy 1999 被引用: 150